Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02006420 · ClinicalTrials.gov registry record
Scleroderma ARFI Imaging of the Skin
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 45
- Enrollment target
NCT02006420 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 45 participants.
The verdict
NCT02006420 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
Scleroderma and other rheumatologic conditions can affect the skin. Scleroderma in particular involves skin thickening and hardening. Currently, looking at the degree that the skin is affected by scleroderma is measured based on a combination of a physical exam and a skin biopsy. The researchers propose to measure skin hardness using ultrasound imaging of elasticity. They will use a technique using acoustic radiation force impulse/shear wave velocity imaging , known as ARFI/SVI). The investigators hypothesize that ARFI/SVI may be able to distinguish between normal skin and skin affected by scleroderma.. This tool may also help to quantify the amount of fibrosis in the skin. This type of radiologic biomarker could be used to help confirm the diagnosis of scleroderma.
Interventions
- DEVICE ARFI-SVI Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2013-12 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02006420
The ClinicalTrials.gov registry entry for NCT02006420 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ARFI-SVI Ultrasound is the first listed.
NCT02006420 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02006420 about?
NCT02006420 is a clinical study titled "Scleroderma ARFI Imaging of the Skin". Scleroderma and other rheumatologic conditions can affect the skin. Scleroderma in particular involves skin thickening and hardening. Currently, looking at the degree that the skin is affected by scleroderma is measured based on a combination of a physical exam and a skin biopsy. The researchers p...
What is the current status of trial NCT02006420?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2013-12. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02006420?
The interventions under investigation include: ARFI-SVI Ultrasound (DEVICE).
Who is sponsoring clinical trial NCT02006420?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.